Guest guest Posted December 31, 2008 Report Share Posted December 31, 2008 http://www.upi.com/Health_News/2008/12/30/FDA_approves_new_HIV_hepatitis_screen/\ UPI-31351230695659/ FDA approves new HIV, hepatitis screen Published: Dec. 30, 2008 at 10:54 PLEASANTON, Calif., Dec. 30 (UPI) -- The U.S. government Tuesday approved a nucleic acid test that screens for less common forms of HIV that recently have appeared in the United States. The U.S. Food & Drug Administration approved the test from the Swiss firm Roche Diagnostics to screen donated blood for HIV-1 Group M RNA, hepatitis C RNA and hepatitis B DNA. The test, called the cobas TaqScreen MPX Test for use on the cobas s 201 system, is a qualitative test for human plasma. The test, which is not intended for use as an aid in diagnosis, is designed to further increase the safety of blood supplies by identifying infections earlier than traditional serology tests -- identification of antibodies in the blood, statement from the drug company said. " Roche is committed to meeting the needs of blood centers with tests and systems that ensure the highest blood safety, " O'Day, head of Roche Molecular Diagnostics, the business area of Roche Diagnostics that developed the test, said in a statement. " Our multiplex test has been widely adopted and has demonstrated excellent performance in blood centers worldwide. " Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.